These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21437840)

  • 1. [Hemicentral retinal artery occlusion due to oral contraceptives].
    Schmidt D; Kramer-Zucker A
    Klin Monbl Augenheilkd; 2011 Aug; 228(8):729-33. PubMed ID: 21437840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side-effect of oral contraceptives: occlusion of branch artery of the retina.
    Leff SP
    Bull Sinai Hosp Detroit; 1976 Oct; 24(4):227-9. PubMed ID: 12308176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cilioretinal artery occlusion and central retinal vein occlusion complicating hyperhomocysteinemia: a case report].
    Berkani Z; Kitouni Y; Belhadj A; Sifi K; Abbadi N; Bellatrache C; Hartani D; Kherroubi R
    J Fr Ophtalmol; 2013 Sep; 36(7):e119-27. PubMed ID: 23731792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fluorescein angiographic study of branch retinal artery occlusion (BRAO) - the retrograde filling of occluded vessels.
    Schmidt D
    Eur J Med Res; 1999 Dec; 4(12):491-506. PubMed ID: 10611053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral contraceptive agents and antithrombin III].
    Kamenov V; Nalbanski B
    Akush Ginekol (Sofiia); 1990; 29(1):60-3. PubMed ID: 1695492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in arterial blood pressure of women using hormonal contraceptives in relation to their cardiovascular history].
    Manuilova IA; Dubnitskaia LV; Korsakov SG
    Akush Ginekol (Mosk); 1989 Jul; (7):48-51. PubMed ID: 2478038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple arterial occlusions and hypertension probably caused by an oral contraceptive: a patient in whom the development of renovascular hypertension has been followed.
    Delin K; Aurell M; Claes G; Teger-Nilsson AC; Wallentin I
    Clin Nephrol; 1976 Oct; 6(4):453-7. PubMed ID: 788979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial safety of a novel monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen over six cycles.
    Rabe T; Hartschuh E; Wahlstrom T; Höschen K; König S
    Contraception; 2010 Oct; 82(4):358-65. PubMed ID: 20851230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The eye and hormones: vascular disorders associated with combined oral contraceptives and pregnancy].
    Villatte-cathelineau B
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):147-52. PubMed ID: 12280201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptive-induced central retinal artery occlusion.
    Rekhi GS; Dheer S
    J Assoc Physicians India; 2002 Aug; 50():1084-5. PubMed ID: 12421041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute opthalmologic complications during the use of oral contraceptives.
    Friedman S; Golan A; Shoenfeld A; Goldman J
    Contraception; 1974 Dec; 10(6):685-92. PubMed ID: 4452242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen.
    Brucker C; Hedon B; The HS; Höschen K; Binder N; Christoph A
    Contraception; 2010 Jun; 81(6):501-9. PubMed ID: 20472117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arterial occlusion in the ocular fundus induced by oral contraceptives].
    Vastag O; Tornóczky J
    Orv Hetil; 1984 Dec; 125(51):3121-5. PubMed ID: 6514354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 mu(g) ethinylestradiol and either 2 mg chlormadinone acetate or 150 mu(g) desogestrel.
    Winkler UH; Daume E; Sudik R; Oberhoff C; Bier U; Hallmann C; Andreas JO; Schindler AE
    Eur J Contracept Reprod Health Care; 1999 Sep; 4(3):145-54. PubMed ID: 10574640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives and panic disorder.
    Deci PA; Lydiard RB; Santos AB; Arana GW
    J Clin Psychiatry; 1992 May; 53(5):163-5. PubMed ID: 1592843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cilioretinal artery occlusion combined with central retinal vein occlusion - a report of two cases and review of the literature.
    Theoulakis PE; Livieratou A; Petropoulos IK; Lepidas J; Brinkmann CK; Katsimpris JM
    Klin Monbl Augenheilkd; 2010 Apr; 227(4):302-5. PubMed ID: 20408080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of hormonal contraceptives on the coagulation system and some of its inhibitors.
    Misz M; Beck P
    Acta Med Hung; 1986; 43(3):301-10. PubMed ID: 2438639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.
    Seeger JD; Loughlin J; Eng PM; Clifford CR; Cutone J; Walker AM
    Obstet Gynecol; 2007 Sep; 110(3):587-93. PubMed ID: 17766604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.